Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 14/20 | 0.67 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.47 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21886880 | 0.93 | GPR119 (0.59) | GPR119 | |
| SCHEMBL28417148 | 0.90 | GPR119 (0.58) | GPR119CHEK2 | |
| SCHEMBL31398187 | 0.88 | GPR119 (0.53) | GPR119 | |
| SCHEMBL24111531 | 0.88 | GPR119 (0.53) | GPR119 | |
| SCHEMBL28420323 | 0.87 | GPR119 (0.55) | GPR119CHEK2 | |
| SCHEMBL31044599 | 0.87 | GPR119 (0.55) | GPR119CHEK2 | |
| SCHEMBL12489357 | 0.85 | GPR119 (0.60) | GPR119 | |
| SCHEMBL29980570 | 0.85 | GPR119 (0.60) | GPR119 | |
| SCHEMBL23311785 | 0.85 | GPR119 (0.57) | GPR119CHEK2 | |
| SCHEMBL17560148 | 0.85 | GPR119 (0.57) | GPR119CHEK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210122763-A1 | OGA INHIBITOR COMPOUNDS | JANSSEN-CILAG S.A. (ES) | 2021-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210122763-A1 | OGA INHIBITOR COMPOUNDS | OGA, OGT, GRN | GPR119 1166/4885ALK 4618/4885CHEK2 575/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.